A nomogram for predicting recurrence in endometrial cancer patients: a population-based analysis

被引:2
作者
Miao, Mengdan [1 ,2 ]
Zhu, Yanping [1 ]
Wang, Lulu [1 ]
Miao, Yifei [2 ]
Li, Rong [1 ]
Zhou, Huaijun [1 ,2 ]
机构
[1] Nanjing Univ, Affiliated Drum Tower Hosp, Med Sch, Nanjing, Peoples R China
[2] Nanjing Med Univ, Dept Radiol, Nanjing Drum Tower Hosp, Clin Coll, Nanjing, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
endometrial cancer; recurrence; risk factor; nomogram; predictive model; ESTRO CONSENSUS CONFERENCE; SPACE INVASION; PATTERNS; OUTCOMES; ADJUVANT; THERAPY; WOMEN; STAGE;
D O I
10.3389/fendo.2023.1156169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveEndometrial cancer recurrence is one of the main factors leading to increased mortality, and there is a lack of predictive models. Our study aimed to establish a nomogram predictive model to predict recurrence in endometrial cancer patients.MethodScreen 517 endometrial cancer patients who came to Nanjing Drum Tower Hospital from 2008 to 2018. All these data are listed as the training group, and then 70% and 60% are randomly divided into verification groups 1 and 2. Univariate, Multivariate logistic regression, stepwise regression were used to select variables for nomogram. Nomogram identification and calibration were evaluated by concordance index (c-index), area under receiver operating characteristic curve (AUC) over time and calibration plot Function. By decision curve analysis (DCA), net reclassification index (NRI), integrated discrimination improvement (IDI), we compared and quantified the net benefit of nomogram and ESMO-ESGO-ESTRO model-based prediction of tumor recurrence.ResultsA nomogram predictive model of endometrial cancer recurrence was established with the eight variables screened. The c-index (for the training cohort and for the validation cohort) and the time-dependent AUC showed good discriminative power of the nomogram. Calibration plots showed good agreement between nomogram predictions and actual observations in both the training and validation sets.ConclusionsWe developed and validated a predictive model of endometrial cancer recurrence to assist clinicians in assessing recurrence in endometrial cancer patients.
引用
收藏
页数:10
相关论文
共 29 条
[1]   Nomograms in oncology: more than meets the eye [J].
Balachandran, Vinod P. ;
Gonen, Mithat ;
Smith, J. Joshua ;
DeMatteo, Ronald P. .
LANCET ONCOLOGY, 2015, 16 (04) :E173-E180
[2]   Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy? [J].
Beavis, Anna L. ;
Yen, Ting-Tai ;
Stone, Rebecca L. ;
Wethington, Stephanie L. ;
Carr, Caitlin ;
Son, Ji ;
Chambers, Laura ;
Michener, Chad M. ;
Ricci, Stephanie ;
Burkett, Wesley C. ;
Richardson, Debra L. ;
Staley, Allison-Stuart ;
Ahn, Susie ;
Gehrig, Paola A. ;
Torres, Diogo ;
Dowdy, Sean C. ;
Sullivan, Mackenzie W. ;
Modesitt, Susan C. ;
Watson, Catherine ;
Veade, Ashely ;
Ehrisman, Jessie ;
Havrilesky, Laura ;
Secord, Angeles Alvarez ;
Loreen, Amy ;
Griffin, Kaitlyn ;
Jackson, Amanda ;
Viswanathan, Akila N. ;
Jager, Leah R. ;
Fader, Amanda N. .
GYNECOLOGIC ONCOLOGY, 2020, 156 (03) :568-574
[3]   Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group [J].
Bendifallah, Sofiane ;
Ouldamer, Lobna ;
Lavoue, Vincent ;
Canlorbe, Geoffroy ;
Raimond, Emilie ;
Coutant, Charles ;
Graesslin, Olivier ;
Touboul, Cyril ;
Collinet, Pierre ;
Darai, Emile ;
Ballester, Marcos .
GYNECOLOGIC ONCOLOGY, 2017, 144 (01) :107-112
[4]   Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings [J].
Bestvina, Christine M. ;
Fleming, Gini F. .
ONCOLOGIST, 2016, 21 (10) :1250-1259
[5]   Current recommendations and recent progress in endometrial cancer [J].
Brooks, Rebecca A. ;
Fleming, Gini F. ;
Lastra, Ricardo R. ;
Lee, Nita K. ;
Moroney, John W. ;
Son, Christina H. ;
Tatebe, Ken ;
Veneris, Jennifer L. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (04) :258-279
[6]   ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up [J].
Colombo, N. ;
Creutzberg, C. ;
Amant, F. ;
Bosse, T. ;
Gonzalez-Martin, A. ;
Ledermann, J. ;
Marth, C. ;
Nout, R. ;
Querleu, D. ;
Mirza, M. R. ;
Sessa, C. .
ANNALS OF ONCOLOGY, 2016, 27 (01) :16-41
[7]   ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up [J].
Colombo, Nicoletta ;
Creutzberg, Carien ;
Amant, Frederic ;
Bosse, Tjalling ;
Gonzalez-Martin, Antonio ;
Ledermann, Jonathan ;
Marth, Christian ;
Nout, Remi ;
Querleu, Denis ;
Mirza, Mansoor Raza ;
Sessa, Cristiana .
RADIOTHERAPY AND ONCOLOGY, 2015, 117 (03) :559-581
[8]   Endometrial cancer [J].
Crosbie, Emma J. ;
Kitson, Sarah J. ;
McAlpine, Jessica N. ;
Mukhopadhyay, Asima ;
Powell, Melanie E. ;
Singh, Naveena .
LANCET, 2022, 399 (10333) :1412-1428
[9]   Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study [J].
Gafita, Andrei ;
Calais, Jeremie ;
Grogan, Tristan R. ;
Hadaschik, Boris ;
Wang, Hui ;
Weber, Manuel ;
Sandhu, Shahneen ;
Kratochwil, Clemens ;
Esfandiari, Rouzbeh ;
Tauber, Robert ;
Zeldin, Anna ;
Rathke, Hendrik ;
Armstrong, Wesley R. ;
Robertson, Andrew ;
Thin, Pan ;
D'Alessandria, Calogero ;
Rettig, Matthew B. ;
Delpassand, Ebrahim S. ;
Haberkorn, Uwe ;
Elashoff, David ;
Herrmann, Ken ;
Czernin, Johannes ;
Hofman, Michael S. ;
Fendler, Wolfgang P. ;
Eiber, Matthias .
LANCET ONCOLOGY, 2021, 22 (08) :1115-1125
[10]   Laparoscopy versus laparotomy for the management of early stage endometrial cancer [J].
Galaal, Khadra ;
Donkers, Hannah ;
Bryant, Andrew ;
Lopes, Alberto D. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10)